Harrow: Positive And Negative Adjustments After Investor Day Offset Each Other
Source: SeekingAlpha
2025-10-15 21:03:41 ET
Article Thesis
I wrote about Harrow, Inc. ( HROW ), a small biotech company focused on acquiring and commercializing ophthalmic pharmaceutical products in the U.S., at the beginning of September. With a price around $37 and a Fair Value estimate of $72.75, derived from a 10-year DCF (Discounted Cash Flow) model, I initiated a half position....
Read the full article on Seeking Alpha
For further details see:
Harrow: Positive And Negative Adjustments After Investor Day Offset Each Other
Harrow Health Inc.
NASDAQ: HROW
HROW Trading
-4.58% G/L:
$33.77 Last:
418,081 Volume:
$35.80 Open:
